R&D Portfolio
New drugs
Development)
Developing innovative pharmaceutical solutions to address unmet medical needs and improve patient life.
Biologics
Development)
Advancing cutting-edge biologics to offer precise and effective solutions for complex health challenges. patient life.
New products
Development)
Introducing high-quality, innovative products to meet evolving market demands and improve healthcare experiences.
C&D (Connect & Development)
Building global partnerships and fostering collaboration to accelerate the development of advanced healthcare solutions.
R&D Objevtives
Development of First/ Best-in-class drugs
Development)
Pushing the boundaries of innovation to develop first and best-in-class drugs that redefine standards of care and offer breakthrough solutions for patients.
Development of next generation Biologics
Development)
Leading the way in next-generation biologics, delivering advanced therapeutic options with enhanced precision, efficacy, and safety.
patient life.
IMD development based on innovative platform technology
Creating improved medicines (IMDs) by leveraging cutting-edge platform technologies to deliver enhanced therapeutic benefits and meet diverse medical needs.
Expanding the scope of external R&D
Development)
Strengthening global collaborations and partnerships to expand external R&D capabilities, accelerating the discovery and development of advanced healthcare solutions.